Boryung Co. Ltd. (003850)
KRX SM KRX SM Primary Summary
Boryung Co. Ltd. (003850) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Boryung Co. Ltd. ever had a stock split?
Boryung Co. Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Jung-Gyun Kim CEO | KRX SM Exchange | KR7003850005 ISIN |
| KR Country | - Employees | 29 Dec 2025 Last Dividend | 2 Jun 2021 Last Split | - IPO Date |
Overview
Boryung Corporation, headquartered in Seoul, South Korea, is a significant player in the pharmaceutical industry, both domestically and internationally. The company has been in the business since 1957, emphasizing its extensive experience and long-standing presence in the market. Originally operating under the name Boryung Pharmaceutical Co., Ltd., it underwent a name change to Boryung Corporation in March 2022. This rebranding reflects its broader commitment to healthcare and pharmaceutical innovation beyond its original scope. It specializes in the manufacturing and sale of a diverse range of pharmaceutical products catering to various medical needs and health conditions.
Products and Services
Boryung Corporation's portfolio spans multiple therapeutic areas, offering advanced medical solutions through prescription drugs. Its product range focuses on key healthcare issues, ensuring a wide impact across several critical diseases and conditions:
- Hypertension: These products are designed to manage and control high blood pressure, a leading risk factor for heart disease and stroke. Boryung's commitment to cardiovascular health is evident in its comprehensive hypertension medication offerings.
- Dyslipidemia: Targeted drugs for dyslipidemia help in regulating cholesterol and triglyceride levels in the blood, important for preventing heart attacks and strokes. Boryung offers medications that help in maintaining a healthy lipid profile.
- Diabetes: Boryung's diabetic care includes treatments that control blood sugar levels. These products are essential for managing diabetes mellitus, preventing complications, and improving the quality of life for those affected by the condition.
- Central Nervous System (CNS): This range includes medications for diseases and disorders affecting the brain and spinal cord, addressing conditions such as epilepsy, Parkinson's disease, and depression, showcasing Boryung's commitment to mental health and neurological conditions.
- Oncology Drugs: Boryung also ventures into oncology, offering drugs aimed at cancer treatment. Their oncology products contribute to cancer care by providing options for therapy and symptom management, reflecting the company's dedication to combating cancer.
